All posts tagged: Ozempic

Kris Jenner reveals she felt ‘really sick’ after taking Ozempic | Hollywood News

Kris Jenner reveals she felt ‘really sick’ after taking Ozempic | Hollywood News

3 min readNew DelhiUpdated: May 8, 2026 08:39 PM IST Ozempic has become a major talking point in the entertainment industry. The rapid weight-loss transformations of several Bollywood celebrities in recent months have fuelled widespread speculation about the drug’s use and possible side effects. Now, Kris Jenner has opened up about her own experience with Ozempic. In a recent interview, the 70-year-old revealed that the medication made her feel “really sick”, before she eventually discovered what she described as a “game changer.” During an appearance on the SHE MD Podcast on Tuesday, Kris said, “I did not do, like, an Ozempic. I tried it. We tried it once when no one knew what it was and it made me really sick.” The TV personality and businesswoman further recalled telling her doctor, Thais Aliabadi, that she is not able to work properly because of her health. “I can’t work anymore. I can’t. I’m so sick. I can’t, like nauseous. And so she goes, ‘Okay, okay. Let’s try something else,’” she said. Kris and Thais “dialed around …

Canada approves for use Dr Reddy’s generic Ozempic version

Canada approves for use Dr Reddy’s generic Ozempic version

Canada has approved an Indian pharma company’s generic version of the anti-diabetes drug Ozempic, for use in the country. Satish Reddy, managing director and chief operating officer of Dr Reddy’s Laboratories. (Bloomberg) Health Canada announced on Tuesday that the generic semaglutide injection from the Hyderabad-headquartered Dr Reddy’s Laboratories had been approved. Dr Reddy’s submission for approval was filed in January 2024. The injection of the popular drug is used to control type 2 diabetes and has also been found effective as a weight loss agent. In a release, Health Canada said not only was this approval the first for the country, it was “the first to be approved in the G7.” Health Canada said it was currently reviewing eight other submissions from different companies. The department said it authorized the drug “after a thorough review of evidence provided by the company, demonstrated” it met its “criteria for safety, efficacy and quality for generic drugs.” It added as in the case of existing products, the Dr Reddy’s semaglutide injection was indicated for the once-weekly treatment of …

Ozempic, Mounjaro and the rise of lookism: Why young Indians are risking it all to lose weight | Eye News

Ozempic, Mounjaro and the rise of lookism: Why young Indians are risking it all to lose weight | Eye News

For years, 28-year-old Aditi has learnt to shrink herself in social spaces and mute herself from conversations, a desperate act to invisibilise herself. “Only my body was visible to others, not my mind. Nobody was concerned about my health or how my hormones swung wild and moody because of PCOS (polycystic ovary syndrome) and a competitive work life. They would instead judge me for being careless. All through my adult years, I only listened: ‘Have you gained weight this month?’ or ‘Your face is looking rounder, try a detox drink, buy a tummy twister, go on so and so diet.’ There was fashion advice to hide my belly bump. So, when my mother chose a champagne-coloured mermaid lehenga for my wedding, thinking it would make me look slim in the photos, she had not thought of the challenge of slipping into it,” she says. Instead of feeling joyful, her midriff sat heavy on her chest as Aditi walked into a beauty and wellness clinic near her West Delhi home to clear up her acne, another …

Indian Pharma’s ‘Sema’ Storm: Over 50 Semaglutide Brands Queue Up As Ozempic Patent Expires | Health and Fitness News

Indian Pharma’s ‘Sema’ Storm: Over 50 Semaglutide Brands Queue Up As Ozempic Patent Expires | Health and Fitness News

Last Updated:March 06, 2026, 07:30 IST From Semaglip, Sematop, Semakind to Semastrike, Semaglyn and Semaril, the pipeline of upcoming Ozempic copycats reads like variations of the semaglutide molecule itself Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. File pic/Reuters If there is one prefix that is likely to dominate prescriptions in India over the coming months, it may well be “Sema”. With key patents around semaglutide—the blockbuster molecule behind drugs like Ozempic and Wegovy—set to expire in India next week, Indian pharmaceutical companies are ready to introduce their own versions. Industry insiders say more than 50 brands are preparing for launch, and a curious pattern is emerging: most of them begin with the same four letters. From Semaglip, Sematop, Semakind, Semester, Semaglide, and Semalup to Semastrike, Semaglyn, Semaril, Semapride, Semalup, and Semalix, the pipeline of upcoming copycat versions of Ozempic reads almost like variations on the original molecule—semaglutide. In fact, industry estimates suggest around 80–85 per cent of brands preparing for launch start with “Sema”, reflecting how companies anchor …

Karan Johar recalls his mother calling him ‘fat, large’, reveals how he actually lost weight: ‘I’m not on Ozempic’

Karan Johar recalls his mother calling him ‘fat, large’, reveals how he actually lost weight: ‘I’m not on Ozempic’

Filmmaker Karan Johar stunned everyone last year with his weight loss transformation. However, his transformation sparked rumours about him using Ozempic for weight loss. In a recent conversation with Aadar Jain and Alekha on The Manyavar Shaadi Show, Karan spoke about how he actually lost weight and also recalled how he once fainted due to dieting. Karan Johar on the dark reality of dieting. Karan Johar recalls his mom calling him fat Karan recalled that while his father thought he just had puppy fat growing up, his mother used to call him out for being overweight. Karan said, “My dad was in delusion land about me. He thought that I had puppy fat, it will go away, he is so handsome. But my mother used to disagree and say, ‘What are you saying, Yash? He is so fat, so large.’ He wanted me to become a hero, and my mother used to roll her eyes saying no way he is capable or should be a hero. She always used to call me out. Punjabi moms …

Karan Johar recalls fainting in college while dieting; says his mother called him ‘fat’ and ‘large’: ‘I am not on Ozempic…’ | Bollywood News

Karan Johar recalls fainting in college while dieting; says his mother called him ‘fat’ and ‘large’: ‘I am not on Ozempic…’ | Bollywood News

Filmmaker Karan Johar made headlines last year with his dramatic weight loss transformation. While he has repeatedly denied the rumours, many netizens claimed that he used Ozempic to shed the kilos. Now, in a recent podcast, Karan dismissed the speculation once again. He also opened up about trying various diets during college and revealed that his mother Hiroo Johar used to call him “fat” and “large” at the time. During a conversation on Manyavar, Karan Johar admitted that while weight loss can be simple, it has been difficult for him due to the demands of his profession. “It’s all very simple if you regiment your life. If you give it some kind of routine..which can’t happen in our job, especially in my profession. We don’t have any weekends or national holidays, it’s very irregular. Everyone is just stress calling me. I don’t reply for three hours to work related things when people tell me to call urgently,” he said. The filmmaker recalled that while his father Yash Johar used to speak in his support and …

Why Ozempic should be used wisely by Indians? Here’s the real reason | Health and Wellness News

Why Ozempic should be used wisely by Indians? Here’s the real reason | Health and Wellness News

Months after launching its weight-loss drug, Danish pharmaceutical giant Novo Nordisk launched its injectable semaglutide for the treatment of Type 2 diabetes last week. It will cost between Rs 8,800 a month for the lowest dose to Rs 11,175 a month for the highest dose. The drug was first approved for the treatment of diabetes in 2017 by the US Food and Drug Administration. However, it soon gained popularity for the significant weight loss it led to, with physicians prescribing it off-label to patients struggling with obesity. In 2021, the FDA officially approved Wegovy — a higher-dose version of semaglutide — as treatment for chronic weight management. While semaglutide — and its successor tirzepatide — took the world by storm, both entered the Indian market only in 2025. The Indian Express spoke to endocrinologists, Dr Shashank Joshi of Lilavati Hospital, Mumbai, and Dr AG Unnikrishnan of Pune’s Chellaram Diabetes Institute. Patients are concerned about continuing the drug indefinitely. Can the dosage be tapered down? Dr Unnikrishnan: Diabetes and obesity are chronic conditions for which people …

Global blockbuster Ozempic injection now available in India

Global blockbuster Ozempic injection now available in India

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits. Ozempic is now available in India as 0.25 mg, 0.5 mg and 1 mg in ‘FlexTouch Pen’ – an easy-to-use, once-weekly pen device, at a starting cost of Rs 2200 per week, the company announced here. Novo Nordisk India Managing Director, Vikrant Shrotriya, said through Ozempic, the company is looking to provide patients with an innovative and accessible therapy for the treatment of type 2 diabetes while also offering meaningful weight management and long-term heart and kidney protection. “We are very judicious in terms of pricing in India. It really remains very competitive, internally and externally as well, to offer at a price like this,” Shrotriya told PTI when asked how Ozempic pricing in India compares with other global markets. “I would say that it still comes under the affordability zone of the pricing, which is at a range for countries similar to India.” Novo Nordisk is marketing Ozempic purely as a treatment …

“My Curves Are Not Going Anywhere”- Tamannaah Bhatia Shuts Down Ozempic Rumours

“My Curves Are Not Going Anywhere”- Tamannaah Bhatia Shuts Down Ozempic Rumours

Tamannaah Bhatia recently shut down Ozempic rumours and opened up about self-acceptance. The actress’ physical transformation has been the topic of conversation for some time now and netizens also accused her of using Ozempic, a drug that helps in weight loss. In a conversation with Harper’s Bazaar India, the Do You Wanna Partner actress said, “I have been in front of the camera since the age of 15 and people have seen me grow up in front of the camera, so there is nothing to hide. Till my late 20s I was a slender body type. That was always my body. This body in which I am right now is technically not new to me. I have grown up like this, and I have stayed like this.”   The actress continued, “This might be new for the Hindi belt of the audience, but I am nearing 100 films, so people have seen my work in so many different films and in so many different bodies, but essentially on the leaner side. But what people need …

Tamannaah Bhatia on Ozempic rumours and inflammation struggles

Tamannaah Bhatia on Ozempic rumours and inflammation struggles

Tamannaah Bhatia, an actor, has recently made headlines for her stunning physical makeover. While some trolls accused her of taking Ozempics, others praised her for her new look. Tamannaah recently addressed the talk and discussed whether she feels forced to lose her curves and comply with global beauty standards. Tamannaah told Harper`s Bazaar India that she has always had a naturally thin figure, particularly in her 20s. She shared, “I have been in front of the camera since the age of 15, and people have seen me grow up in front of the camera, so there is nothing to hide. Till my late 20s, I was a slender body type. That was always my body. This body in which I am right now is technically not new to me. I have grown up like this, and I have stayed like this.” Tamannah Bhatia reacted to the Ozempic debate However, the performer revealed that she fought to control her weight during the COVID pandemic, which she believes is when the Hindi audience formed an opinion of …